OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revisiting the Relationship Between Alzheimer’s Disease and Cancer With a circRNA Perspective
Danze Chen, Shijia Hao, Jianzhen Xu
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 12

Showing 12 citing articles:

Exosomes and non-coding RNAs: bridging the gap in Alzheimer’s pathogenesis and therapeutics
Chunhui Guo, You Yanqiu, Jibing Chen, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Open Access | Times Cited: 1

A review and analysis of key biomarkers in Alzheimer’s disease
Zhihao Zhang, Xiangtao Liu, Suixia Zhang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5

The Role and Clinical Potentials of Circular RNAs in Prostate Cancer
Mohammad Taheri, Sajad Najafi, Abbas Basiri, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32

Dynamics and Role of Covalently-closed Circular RNAs in Alzheimer's Disease: A Review of Experimental and Bioinformatics Studies
Nikta Zafarjafarzadeh, Elham Feridouni, Sahar Saeedi Moghaddam, et al.
Neurobiology of Aging (2025)
Closed Access

In-vivo neuronal dysfunction by Aβ and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease
Lazaro M. Sanchez-Rodriguez, Ahmed Faraz Khan, Quadri Adewale, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 3

MicroRNA-Target Interaction Regulatory Network in Alzheimer’s Disease
Aleksander Turk, Tanja Kunej, Borut Peterlin
Journal of Personalized Medicine (2021) Vol. 11, Iss. 12, pp. 1275-1275
Open Access | Times Cited: 17

Computational Drug Repurposing Based on a Recommendation System and Drug–Drug Functional Pathway Similarity
Mengting Shao, Leiming Jiang, Zhigang Meng, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1404-1404
Open Access | Times Cited: 9

CRIT: Identifying RNA-binding protein regulator in circRNA life cycle via non-negative matrix factorization
Mengting Shao, Shijia Hao, Leiming Jiang, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 30, pp. 398-406
Open Access | Times Cited: 8

Bioinformatics and Experimental Identification of circ_0001535 Associated with Diagnosis and Development of Alzheimer's Disease
Mingming Ma, Dandan Xie, Jing Zhao
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 4
Open Access | Times Cited: 3

Circular RNAs and inflammation: Epigenetic regulators with diagnostic role
Soudeh Ghafouri‐Fard, Hamed Shoorei, Toofan Sabernia, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154912-154912
Open Access | Times Cited: 2

Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance
Divya Adiga, Sangavi Eswaran, Sriharikrishnaa Srinath, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1615-1634
Closed Access

Transcriptomic signatures of Aβ- and tau-induced neuronal dysfunction reveal inflammatory processes at the core of Alzheimer’s disease pathophysiology
Lazaro M. Sanchez-Rodriguez, Ahmed Faraz Khan, Quadri Adewale, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top